A Smart Investment: The Health, Education, and Economic Returns of Malaria Chemoprevention in School-Aged Children Across Ten High-Burden Countries
This study demonstrates that malaria chemoprevention for school-aged children across ten high-burden sub-Saharan African countries is a highly cost-effective investment, generating substantial societal net benefits through improved health, reduced school absenteeism, and enhanced educational outcomes, with benefit-cost ratios ranging from 3.71 to 39.5.